Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
New in Frontiers in Oncology: comparative profiling study of newly approved kinase inhibitors
New in Frontiers in Oncology: comparative profiling study of newly approved kinase inhibitors [...]
On-demand webinar on cancer genomics
On-demand webinar on cancer genomics Cancer genomics is key to Oncolines’ cancer [...]
Oncolines Hosts Webinar: How to Select the Best Platform for Testing Drug Combinations
Many cancer treatments are combination therapies. Combining drugs can improve therapy response, prevent drug resistance, or [...]
PREMIUM BENEFITS OF ONCOLINES BIOCHEMICAL ASSAY PLATFORMS: Protein Kinases, Drug-Target Interactions, Differentiation
Screening services to find compounds with the best structure activity relationship
Determination of kinetic and activity-based selectivity
Differentiation of compounds by binding on- and off-rates
Biochemical and cell-based profiling under one roof
Science driven technology platforms like ResidenceTimer™
Short turnaround times: gain access to your data in weeks, not months
